SAN DIEGO, March 8, 2012 /PRNewswire/ -- Amylin
Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the
Barclays Capital Global Healthcare Conference in Miami on Wednesday,
March 14, 2012 at 11:15 a.m.
ET / 8:15 a.m. PT.
David Maggs, M.D., vice president,
medical research and development at Amylin Pharmaceuticals, will
provide a corporate overview.
The presentation will be webcast through the "Investors" section
of Amylin's corporate website at www.amylin.com, and a recording
will be made available following the event. To access the live
webcast, please log on to Amylin's site approximately fifteen
minutes prior to the presentation to register and download any
necessary audio software.
About Amylin Pharmaceuticals
Amylin Pharmaceuticals is a biopharmaceutical company
dedicated to improving lives of patients through the discovery,
development and commercialization of innovative medicines. Amylin
is committed to delivering novel therapies that transform the way
diabetes and other metabolic disorders are treated. Amylin is
headquartered in San Diego, Calif.
and has a commercial manufacturing facility in Ohio. More information about Amylin
Pharmaceuticals is available at www.amylin.com.
SOURCE Amylin Pharmaceuticals, Inc.